Detalhe da pesquisa
1.
L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fibrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Respir Res
; 24(1): 217, 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674160
2.
CD123 a Therapeutic Target for Acute Myeloid Leukemia and Blastic Plasmocytoid Dendritic Neoplasm.
Int J Mol Sci
; 24(3)2023 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36769040
3.
Ex Vivo Anti-Leukemic Effect of Exosome-like Grapefruit-Derived Nanovesicles from Organic Farming-The Potential Role of Ascorbic Acid.
Int J Mol Sci
; 24(21)2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958646
4.
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells.
Eur Respir J
; 58(6)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413153
5.
Endothelial Progenitors in the Tumor Microenvironment.
Adv Exp Med Biol
; 1263: 85-115, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588325
6.
The small-molecule compound AC-73 targeting CD147 inhibits leukemic cell proliferation, induces autophagy and increases the chemotherapeutic sensitivity of acute myeloid leukemia cells.
Haematologica
; 104(5): 973-985, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467201
7.
Mechanisms of anti-cancer effects of ascorbate: Cytotoxic activity and epigenetic modulation.
Blood Cells Mol Dis
; 69: 57-64, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28954710
8.
Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fbrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients.
Respir Res
; 24(1): 228, 2023 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37742000
9.
Conditioned medium from human umbilical vein endothelial cells markedly improves the proliferation and differentiation of circulating endothelial progenitors.
Blood Cells Mol Dis
; 61: 58-65, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27667168
10.
Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
Blood Cells Mol Dis
; 55(4): 336-46, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26460257
11.
Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines.
Ann Hematol
; 94(11): 1807-16, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26264692
12.
Endothelial progenitors.
Blood Cells Mol Dis
; 52(4): 186-94, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24332583
13.
Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting.
Tumori
; 110(2): 88-95, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772924
14.
CAR-T Cell Therapy for T-Cell Malignancies.
Mediterr J Hematol Infect Dis
; 16(1): e2024031, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468828
15.
CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia.
Mediterr J Hematol Infect Dis
; 16(1): e2024010, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223477
16.
CAR-T Cell Therapy for Follicular Lymphomas.
Mediterr J Hematol Infect Dis
; 16(1): e2024012, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223488
17.
AC-73 and Syrosingopine Inhibit SARS-CoV-2 Entry into Megakaryocytes by Targeting CD147 and MCT4.
Viruses
; 16(1)2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38257782
18.
The clinical value of identifying genetic abnormalities that can be targeted in cholangiocarcinomas.
Expert Rev Anticancer Ther
; 23(2): 147-162, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36654529
19.
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.
Curr Oncol
; 30(1): 610-640, 2023 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661697
20.
Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin.
Technol Cancer Res Treat
; 22: 15330338221128689, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872875